HomeANAB • NASDAQ
add
AnaptysBio Inc
Previous close
$35.18
Day range
$33.49 - $36.15
Year range
$13.36 - $41.31
Market cap
1.06B USD
Avg Volume
279.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 10.97M | 217.08% |
Operating expense | 9.30M | -12.97% |
Net income | -46.66M | -17.10% |
Net profit margin | -425.30 | 63.07% |
Earnings per share | -1.71 | -14.00% |
EBITDA | -40.17M | -0.47% |
Effective tax rate | -0.02% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 350.80M | -18.32% |
Total assets | 427.38M | -17.35% |
Total liabilities | 417.50M | 13.25% |
Total equity | 9.88M | — |
Shares outstanding | 27.45M | — |
Price to book | 97.72 | — |
Return on assets | -24.20% | — |
Return on capital | -26.38% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -46.66M | -17.10% |
Cash from operations | -21.32M | 16.08% |
Cash from investing | -2.44M | 88.06% |
Cash from financing | 41.89M | 410.48% |
Net change in cash | 18.13M | 130.54% |
Free cash flow | -14.65M | 9.78% |
About
Founded
2005
Headquarters
Website
Employees
117